Anxiety and depression are more common among diabetic patients than general population and can impact on treatment. The aim of this study is to screen a random selection of diabetic patients attending the diabetes clinic of Shahid Mohammadi hospital, Iran for anxiety and depression. 100 patients were surveyed using a valid and reliable measure for anxiety and depression. Data analyzed using SPSS 13 software. Prevalence of depression and anxiety was 50 and 67 percent respectively. Both depression and anxiety was more common among female patients, those with type 2 diabetes and those had at least one complication of diabetes. We report a very high prevalence of anxiety and depression in these patients. Routine assessment and treatment for anxiety and depression is indicated. Further research on the reason for the high incidence of depression in this patient group is warranted.
Introduction
Diabetes mellitus is one of the most prevalent diseases worldwide. It is associated with high mortality and morbidity including renal, retinal and vascular complications.(1) Depression is also a common psychiatric disorder among diabetic patients. Prevalence of major depression was 8.3% in a survey among U.S adults with diabetes aged 18 years and older. (2) In Bangladesh the prevalence was higher with 22% of males and 30.5% of females with diabetes diagnosed with depressive symptoms.(3) Some studies reported that more than half of patients with diabetes are clinically depressed (4) . Depression is more prevalent among females(3), patients with type 2 diabetes (5) and those who are treated with insulin (2) . Results of longitudinal studies suggest that depression is associated with poor glycemic control and progression of diabetic retinopathy (6) and psychiatric treatment in diabetes care may be necessary to achieve improved glycemic control in this population. (3) Studies from Iran suggest higher prevalence of depression and anxiety among diabetic patients. (7) In Isfahan the prevalence of depressive disorder were 53% (75% women and 25% men) and 14% of patients have anxiety disorders.(8) Depression was observed in 53.3% of males and 57.7% of females in Kashan(9) and 71.6% of nonInsulin dependent diabetic patients in Semnan(10) and also 72.2% of diabetic patients in Ahwaz. In similar studies in Iran significant associations were reported between depression and the type of diabetes mellitus, and particularly between depression and insulin therapy. (11) Another study in Iran showed that 40.6% have moderate to severe depression on the Beck test.(12) There is a significant difference between depressed and nondepressed individuals regarding gender, complications of disease, duration of diabetes and age.(13) The duration of disease, using Insulin and being hypertensive simultaneously is correlated with major depression in some study. (14) But data on prevalence of depression in For each question in the Beck's inventory a value between 0 and 3 was possible and for each patient sum of the questions' score was considered which could range from 0 to 63. For each patients sum of the scores calculated and described as follows:
Depression questionnaire Less than 9 = without depression 10 to 18 = mild depression 19 to 29 = moderate depression 30 to 40 = severe depression 40 and more = very severe depression Anxiety questionnaire Less than 7 = without anxiety 8 to 15 = mild anxiety 15 to 25 = moderate anxiety 25 to 63 = sever anxiety Data was analysed using SPSS13 software and descriptive statistics and also chi-square and Fisher's exact tests.
Results
Among the participants (N=100) 21 were male and 79 were female. Ninety four were married and 6 were single. Ten had type 1 diabetes and 90 type 2 diabetes. The mean age of participants was 48 years. Forty seven suffered from hypertension, 51 had eye problems and 22 had renal problems. Seventy five patients had at least one of the complications of diabetes. Four patients had diabetic foot complications.
In our study the prevalence of depression and anxiety was 50% and 67% respectively. Table 1 shows the prevalence of depression and anxiety according its severity. Both depression and anxiety was more common among female patients, those with type 2 diabetes and those had at least one complication of diabetes as illustrated in Table 2 and 3.
Discussion
We report the first systematic screening for anxiety and depression at this center. Other studies in Iran reported high prevalence of anxiety and depression relative to other countries. The prevalence is reported 53%, 57.7% and 72.2% in Isfahan, Kashan and Ahwaz respectively compared with 8.3% in U.S and 22% and 30.5% in Bangladesh. (2, 3, 8, 9, 11) We can only speculate about the reasons for this difference and further research is warranted.
We acknowledge several limitations chiefly that the questionnaires was completed by the participant in front of other patients and the clinic nurse which may have had a bearing on the results.(16) However all similar studies in Iran apply this method and so our results may be said to be comparable. Therefore we suggest that our results reflect the approach to screening as reported elsewhere and could be used to identify those at risk of anxiety and depression in diabetic patients at this center. (17) Studies on prevalence of depression in Iran suggest higher rates relative to other countries. Therefore one might surmise that the prevalence of depression and anxiety in diabetic patients in Iran may reflect cultural issues. The rate of depression is reported to be more than 20% in Tehran (Capital of Iran). (18) In Hormozgan the prevalence of depression has been estimated to be as high as 60% among nursing students and about 50% among medical students. (19) The higher prevalence among diabetics may also reflect the older demographic of this population. In Kerman 18.6% of persons over 50 years old had borderline depression and 60% overall had some symptoms of depression. (20) These data however cannot be fully explained and we recommend further research. 
